LncRNA-epidermal growth factor receptor (EGFR), which is upregulated in Tregs, promotes immune evasion of hepatocellular carcinoma by stimulating Treg differentiation and suppressing cytotoxic T lymphocyte (CTL) activation [22]. The gene discussed is EGFR; the disease is hepatocellular carcinoma.